Switch to:
Chemocentryx Inc (NAS:CCXI)
EV/EBITDA
-5.19 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Chemocentryx Inc's enterprise value is $226.75 Mil. Chemocentryx Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $-43.68 Mil. Therefore, Chemocentryx Inc's EV/EBITDA ratio for today is -5.19.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Chemocentryx Inc's stock price is $7.20. Chemocentryx Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2014 was $-1.02. Therefore, Chemocentryx Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Chemocentryx Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=226.753/-43.684
=-5.19

Chemocentryx Inc's current Enterprise Value is $226.75 Mil.
Chemocentryx Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was -9.38 (Dec. 2013 ) + -11.373 (Mar. 2014 ) + -12.123 (Jun. 2014 ) + -10.808 (Sep. 2014 ) = $-43.68 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Chemocentryx Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=7.20/-1.023
=

Chemocentryx Inc's share price for today is $7.20.
Chemocentryx Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was -0.223 (Dec. 2013 ) + -0.27 (Mar. 2014 ) + -0.28 (Jun. 2014 ) + -0.25 (Sep. 2014 ) = $-1.02.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Chemocentryx Inc Annual Data

Dec09Dec10Dec11Dec12Dec13
ev2ebitda 0.000.000.000.000.000.000.000.00-7.64-3.02

Chemocentryx Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebitda -50.05-29.46-7.64-10.67-12.20-2.97-3.02-3.90-3.64-2.56
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK